Globe Life (GL) is trading higher today as the market digests incremental positive sell-side signals, including a recent price-target bump from Wells Fargo to $171 (from $170) while maintaining an Overweight rating. The stock’s gain looks sentiment-driven rather than tied to a new company filing or a fresh earnings release, with traders leaning into the steady drumbeat of supportive analyst targets and the broader “higher-for-longer” earnings narrative around the name.

GL has seen a series of target and view updates over recent months. TD Cowen previously raised its price target to $199 (from $182) and kept a Buy rating, reinforcing the view that the company can compound earnings and return capital to shareholders. Even when opinions diverge—such as Evercore ISI expressing caution that assumptions embedded in longer-dated guidance could be aggressive—the overall target range has remained elevated, helping support dip-buying behavior.

The next near-term catalyst is the upcoming earnings report (late April 2026 based on company/market schedules), where investors will focus on premium growth trends, underwriting margins, and the pace of share repurchases. Any reaffirmation of full-year 2026 expectations—or signs that capital return is accelerating—could keep analysts comfortable with higher targets, while any margin softness could pressure the multiple after the recent run.